Yao, Wei

Glucocorticoid-treated mice have localized changes in trabecular bone material properties and osteocyte lacunar size that are not observed in placebo-treated or estrogen-deficient mice

Lane, N. E., Yao, W., Balooch, M., Nalla, R. K., Balooch, G., Habelitz, S., Kinney, J. H., & Bonewald, L. F. (2006) · Journal of Bone and Mineral Research

Bone health and osteoporosis researchBone Metabolism and Diseases

Cited by 355

Glucocorticoid excess in mice results in early activation of osteoclastogenesis and adipogenesis and prolonged suppression of osteogenesis: a longitudinal study of gene expression in bone tissue from glucocorticoid-treated mice

Yao, W., Cheng, Z., Busse, C., Pham, A., Nakamura, M. C., & Lane, N. E. (2008) · Arthritis & Rheumatism

Bone Metabolism and DiseasesBone health and osteoporosis research

Cited by 241

Glucocorticoid induced autophagy in osteocytes

Xia, X., Kar, R., Gluhak-Heinrich, J., Yao, W., Lane, N. E., Bonewald, L. F., Biswas, S. K., Lo, W.-K., & Jiang, J. X. (2010) · Journal of Bone and Mineral Research

Autophagy in Disease and TherapyBone Metabolism and Diseases

Cited by 193

Glucocorticoid dose determines osteocyte cell fate

Jia, J., Yao, W., Guan, M., Dai, W., Shahnazari, M., Kar, R., Bonewald, L., Jiang, J. X., & Lane, N. E. (2011) · The FASEB Journal

Bone Metabolism and DiseasesAutophagy in Disease and Therapy

Cited by 157

Glucocorticoid-induced bone loss in mice can be reversed by the actions of parathyroid hormone and risedronate on different pathways for bone formation and mineralization

Yao, W., Cheng, Z., Pham, A., Busse, C., Zimmermann, E. A., Ritchie, R. O., & Lane, N. E. (2008) · Arthritis & Rheumatism

Bone health and osteoporosis researchBone Metabolism and Diseases

Cited by 128

Changes in serum receptor activator of nuclear factor-κB ligand, osteoprotegerin, and interleukin-6 levels in patients with glucocorticoid-induced osteoporosis treated with human parathyroid hormone (1-34).

Buxton, E. C., Yao, W., & Lane, N. E. (2004) · The Journal of Clinical Endocrinology & Metabolism

Bone Metabolism and DiseasesBone health and osteoporosis research

Cited by 79

Higher doses of bisphosphonates further improve bone mass, architecture, and strength but not the tissue material properties in aged rats

Shahnazari, M., Yao, W., Dai, W., Wang, B., Ionova-Martin, S. S., Ritchie, R. O., Heeren, D., Burghardt, A. J., Nicolella, D. P., Kimiecik, M. G., et al. (2010) · Bone

Bone health and osteoporosis researchBone health and treatments

Cited by 46

The aminobisphosphonate risedronate preserves localized mineral and material properties of bone in the presence of glucocorticoids

Balooch, G., Yao, W., Ager, J. W., Balooch, M., Nalla, R. K., Porter, A. E., Ritchie, R. O., & Lane, N. E. (2007) · Arthritis & Rheumatism

Bone health and osteoporosis researchBone health and treatments

Cited by 37

Prevention of glucocorticoid induced bone changes with beta-ecdysone

Dai, W., Jiang, L., Lay, Y.-A. E., Chen, H., Jin, G., Zhang, H., Kot, A., Ritchie, R. O., Lane, N. E., & Yao, W. (2015) · Bone

Bone health and osteoporosis researchBone Metabolism and Diseases

Cited by 30

Beta-Ecdysone Protects Mouse Osteoblasts from Glucocorticoid-Induced Apoptosis In Vitro

Dai, W.-W., Wang, L.-B., Jin, G.-Q., Wu, H.-J., Zhang, J., Wang, C.-L., Wei, Y.-J., Lee, J.-H., Lay, Y.-A., & Yao, W. (2017) · Planta Medica

Bone Metabolism and DiseasesBone health and osteoporosis research

Cited by 22

β-Ecdysone Augments Peak Bone Mass in Mice of Both Sexes

Dai, W., Zhang, H., Zhong, Z. A., Jiang, L., Chen, H., Lay, Y.-A. E., Kot, A., Ritchie, R. O., Lane, N. E., & Yao, W. (2015) · Clinical Orthopaedics & Related Research

Bone health and osteoporosis researchBone Metabolism and Diseases

Cited by 15